Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Ten Biotech To Short.

|Includes: Alnylam Pharmaceuticals, Inc. (ALNY), BMRN, CLDX, DRNA, IONS, PRTK, RGLS, SRRA, TGTX, TTOO

In line with an overvaluation of the biotech market, several stocks are SHORT in my portfolio. The analysis includes days to cover, ROA and ROE, P/S and P/E, EPS, differences between targeted market size, revenues and operating expenses. A difference between opposite trend in days to cover and share price was a red flag to dig further and to determine an overall valuation and analysis of the company. Annual projected revenues at 95 percentile below 2014/2015 due to macroeconomic factors. Long term debt and a dry pipeline were added to a final qualitative analysis.

(NASDAQ:BMRN)(NASDAQ:CLDX)(NASDAQ:ALNY)(DNAI)(NASDAQ:DRNA)(NASDAQ:IONS)(NASDAQ:PRTK)(NASDAQ:RGLS)(NASDAQ:TGTX)(NASDAQ:TTOO)

Disclosure: I am/we are short ALNY, BMRN, CLDX, DNAI, DRNA, IONS, PRTK, RGLS, TGTX, TTOO.